Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ryan Nelson

Executive Editor

Washington, D.C.
Ryan Nelson is managing editor of Informa’s Rose Sheet and the head of its cosmetics content channel, with particular expertise in evolving regulatory and legal issues. He’s been covering FDA-regulated industries for going on 15 years, previously reporting for the Gray Sheet (now Medtech Insight) where he handled beats including Capitol Hill and Emerging Technology. He began his career teaching English Literature to 9th grade boys at a private boarding school in Chattanooga, Tennessee, a role he misses only occasionally. Ryan is based in Informa’s Washington, D.C. office.

Latest From Ryan Nelson

US Rep. Pallone Demands Answers From FDA On Seeming Hair-Smoothing Formaldehyde Ban ‘Reversal’

Internal FDA emails obtained by the Environmental Working Group through a FOIA request indicate that the agency was moving toward rulemaking in 2016 to restrict or prohibit use of formaldehyde in heated hair-straightening cosmetics, but seemingly abandoned the initiative. That has Congress, NGOs and other stakeholders asking questions and renewing calls for cosmetics regulatory reform.

United States FDA

Edgewell Seeks Dismissal Of Wet Ones ‘99.99%’ Germ-Kill Suit

The US FDA has primary jurisdiction over labeling claims on OTC consumer antiseptic rubs, and state false advertising claims lodged by the plaintiff are preempted by federal law, Edgewell Personal Care argues in its motion to dismiss a proposed class action in California federal court regarding Wet Ones germ-killing claims.

United States Legal Issues

FDA Advises Caution, Consultation Before Using 99.99% Germ-Killing Claims On Sanitizers

Manufacturers considering use of the popular 99.99% germ-kill claim on hand sanitizer products should consult the Office of Compliance, said Division of Nonprescription Drug Products director Theresa Michele during a recent industry workshop. “Be very, very cautious about the claims you are making,” she said.

United States FDA

EU’s SCCS Taking Comments On Cosmetic Nanomaterial Prioritization Based On Risk Signals

UV filters bisoctrizole, tris-biphenyl triazine and titanium dioxide are high on the Scientific Committee on Consumer Safety’s prioritized list of nanomaterials with known uses in cosmetics, based on physicochemical, exposure and other aspects that signal potential risks to consumers.

Europe Cosmetic Ingredients

CV Sciences Reboots PlusCBD Brand While Counting On New Immunity Products During Flu Season

CV Defense, the second launch in the firm’s new immune-support line (without cannabidiol), is built around palmitoylethanolamide and other nutrients and botanicals to “optimize immune response.” CV Sciences touts the immunity range as complementary to its PlusCBD brand, which is in the process of rolling out dozens of new products in updated packaging.

United States Cannabidiol CBD

EU’s Sustainable Chemicals Strategy Lacks Industry ‘Game Plan’ To Support Innovation, Competitiveness

BASF CEO Martin Brudermüller, newly announced as president of Cefic, strikes an optimistic note in a 15 October open letter regarding European Green Deal prospects. However, industry advocates including Cefic have major concerns about the Commission’s Chemicals Strategy for Sustainability released the day before.

Europe Regulation
See All
UsernamePublicRestriction

Register